The Adjuvanted Recombinant Zoster Vaccine in Adults Aged ≥65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine

por Dagnew, Alemnew F, Klein, Nicola P, Hervé, Caroline, Kalema, George, Di Paolo, Emmanuel, Peterson, James, Salaun, Bruno, Schuind, Anne
Publicado 2020

8. The Adjuvanted Recombinant Zoster Vaccine (RZV) Confers Long-term Protection Against Herpes Zoster: Interim Results of an Extension Study (ZOSTER-049) of Two Clinical Trials (ZO...

por Boutry, Céline, Hastie, Andrew, Shi, Meng, Diez-Domingo, Javier, Tinoco, Juan Carlos, Yu, Chong-Jen, Pirrotta, Paola, Kalema, George, Schuind, Anne
Publicado 2020

1956. Persistence of Immune Response and Safety of an Adjuvanted Recombinant Zoster Vaccine in Older Adults Previously Vaccinated with a Live-Attenuated Herpes Zoster Vaccine: End-...

por Mrkvan, Tomas, Campora, Laura, Catteau, Grégory, Douha, Martine, Grupping, Katrijn, Herve, Caroline, Kalema, George, Heineman, Thomas, Klein, Nicola P, Lal, Himal, Oostvogels, Lidia, Schuind, Anne
Publicado 2018

Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials

por Oostvogels, Lidia, Heineman, Thomas C., Johnson, Robert W., Levin, Myron J., McElhaney, Janet E., Van den Steen, Peter, Zahaf, Toufik, Dagnew, Alemnew F., Chlibek, Roman, Diez-Domingo, Javier, Gorfinkel, Iris S., Hervé, Caroline, Hwang, Shinn-Jang, Ikematsu, Hideyuki, Kalema, George, Lal, Himal, McNeil, Shelly A., Mrkvan, Tomas, Pauksens, Karlis, Smetana, Jan, Watanabe, Daisuke, Weckx, Lily Yin, Cunningham, Anthony L.
Publicado 2019